Back to Search Start Over

A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion

Source :
Respiratory Therapeutics Week. September 2, 2024, 790
Publication Year :
2024

Abstract

2024 SEP 2 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Details

Language :
English
ISSN :
15436659
Database :
Gale General OneFile
Journal :
Respiratory Therapeutics Week
Publication Type :
News
Accession number :
edsgcl.806791963